Skip to content
Review Open access

Control Algorithms for Adaptive Deep Brain Stimulation in Parkinson's Disease.

Sep 2026 · IEEE Reviews in Biomedical Engineering · Vol PP, pp. 1-18 · 0 citations
Medicine

TL;DR

This review provides an overview of control algorithms used in computational, animal and human studies of aDBS in Parkinson's disease to date, finding only relatively simple aDBS algorithms have been used clinically.

Abstract

Thirty years on from the introduction of deep brain stimulation as a therapy for Parkinson's disease, adaptive deep brain stimulation (aDBS) is poised to transform neural stimulation for the treatment of motor disorders. Implementation of aDBS has been facilitated by the identification of biomarkers that reflect patients' clinical states and the introduction of hardware allowing simultaneous sensing and stimulation. However, the most appropriate algorithms for aDBS remain unclear. This review provides an overview of control algorithms used in computational, animal and human studies of aDBS in Parkinson's disease to date. Although shown to be effective and well-tolerated, only relatively simple aDBS algorithms have been used clinically. Computational studies have explored a wider range of more advanced algorithms which promise superior performance but need to be rigorously tested and compared against clinically-tested techniques before translating to patients. The need for comparative studies is further driven by advances in machine learning, which promise patient-specific programming solutions but require large datasets and have high computational requirements. Understanding the advantages and limitations of these different algorithms is critical for aDBS to reach its potential and enable personalized treatment to provide maximum patient benefit.

Read PDF

Similar papers

Review Sep 2026

From beta thresholds to learned control: machine learning in adaptive deep brain stimulation.

Deep brain stimulation (DBS) has transformed the treatment of Parkinson's disease by modulating pathological brain circuits, yet conventional continuous stimulation represents a one-size-fits-all approach that cannot adapt to fluctuating symptoms or individual variations in disease expression. The February 2025 FDA app...

Girishkumar Sivakumar · 0 citations
Open access Aug 2026

Volitional deep brain stimulation following brain-computer interface training for Parkinson's disease

Volitional DBS (vDBS)--a paradigm in which patients use brain-computer interface (BCI) training to learn self-regulation of a neural signal that then controls closed-loop DBS)--is demonstrated, establishing that volitional control of intracranial neurostimulation is achievable without the need of an externalized manual...

J.-X. Zhang, J. Suh, P. Daniel et al. · 0 citations
Review Sep 2026

Adaptive versus conventional deep brain stimulation for bradykinesia in Parkinson's disease: a comparative effectiveness analysis.

Adaptive DBS is technically feasible and offers a promising approach to individualized stimulation, but its comparative clinical value remains uncertain and larger randomized trials are needed before superiority over conventional stimulation can be established.

Nana Tchantchaleishvili, Tariel Natsvaladze, Andrii M. Netliukh et al. · 0 citations
Review Open access 2026

DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE: A REVIEW OF EFFECTIVENESS, RISKS, AND PROSPECTS

Deep brain stimulation (DBS) is one of the most effective surgical interventions for neurodegenerative diseases (NDDs), particularly Parkinson's disease (PD). Although the technique originated in the 1950s and 1960s to treat chronic pain and psychiatric disorders, modern advancements targeting the subthalamic nucleus (...

F. A. Yusupov, M. Abdykadyrov · 0 citations
Review Open access Sep 2026

Rethinking the role of animal models in adaptive deep brain stimulation: From feasibility to mechanistic and disease-modifying insights.

BACKGROUND Adaptive deep brain stimulation (aDBS) has emerged as an advanced neuromodulation approach capable of dynamically adjusting stimulation parameters based on real-time biomarkers, thereby overcoming the limitations of conventional continuous DBS (cDBS). While early animal studies were instrumental in establish...

M. Guidetti, H. Ali, A. Loh et al. · 0 citations
Open access Aug 2026

Clinical rationale for the optimal therapeutic window for deep brain stimulation in Parkinsonʼs disease

Background. Parkinsonʼs disease remains one of the most rapidly progressive neurodegenerative disorders, leading to early disability and a substantial decline in patient quality of life. Although pharmacotherapy provides high efficacy in the initial stages, long-term levodopa therapy inevitably results in motor fluctua...

N. Mykhailovska, T. Slobodin · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.